Isoket (Isosorbide Dinitrate)

Isoket (isosorbide dinitrate) belongs to the organic nitrate class and is employed in the cardiovascular therapeutic area to relieve myocardial ischemia, reduce cardiac workload, and improve hemodynamics in acute settings.

• Angina pectoris: provides rapid relief of chest pain by dilating coronary arteries and decreasing myocardial oxygen demand.
• Acute heart failure: lowers preload and afterload, enhancing cardiac output and relieving pulmonary congestion.
• Myocardial ischemia during stress testing: helps prevent ischemic episodes by improving coronary blood flow.

• Isosorbide dinitrate is a prodrug that is metabolized to release nitric oxide (NO) within vascular smooth muscle. NO activates soluble guanylate cyclase, increasing cyclic GMP levels, which leads to relaxation of smooth muscle cells, vasodilation of veins and arteries, reduced venous return, and decreased myocardial oxygen consumption. The resultant decrease in cardiac preload and afterload further alleviates the workload on the heart.

Isoket may be associated with several adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Headache: throbbing pain often occurring shortly after infusion.
• Hypotension: transient drop in blood pressure, may cause dizziness.
• Flushing: warm sensation and reddening of the skin.
• Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects

• Severe hypotension: marked blood pressure fall leading to syncope.
• Methemoglobinemia: elevated methemoglobin causing cyanosis and hypoxia.
• Allergic reaction: rash, itching, swelling, or anaphylaxis.

When using Isoket, clinicians should observe specific precautions to ensure patient safety and drug stability.

• Blood pressure monitoring: check systolic and diastolic values before and during infusion.
• Avoid PDE5 inhibitors: concurrent use with sildenafil or similar agents can cause profound hypotension.
• Caution in anemia: patients with low hemoglobin may experience exaggerated vasodilatory effects.
• Assess tolerance: prolonged therapy may lead to nitrate tolerance, requiring drug‑free intervals.
• Dose adjustment in organ impairment: consider reduced dosing in severe hepatic or renal dysfunction.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Isoket can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Phosphodiesterase‑5 inhibitors (e.g., sildenafil): may cause life‑threatening hypotension.
• Other nitrates or nitroglycerin: additive vasodilatory effect leading to severe blood pressure drop.
• Antihypertensive agents (e.g., ACE inhibitors, beta‑blockers): can amplify hypotensive response.
• Alcohol: enhances vasodilatory action and may increase dizziness.

Moderate Interactions (Monitor Closely)

• Diuretics: may potentiate volume depletion and hypotension.
• Beta‑blockers: combined effect on heart rate and blood pressure requires monitoring.
• Calcium channel blockers: may increase risk of reflex tachycardia.